HOME >> MEDICINE >> NEWS
4D proton therapy, radiation-resistant tumors, interpreting medical images

ant Secretary of Washington State's Division of Environmental Health, will describe emergency preparedness and terrorism response training for professionals at the statewide level. On Thursday, July 28, at 10:00 AM, Debra McBaugh, the chairperson of the Conference of Radiation Control Program Directors, will discuss how medical physicists have unique skills that can assist states in terrorism response. McBaugh was part of the State of Washington's team that participated in a national exercise that included responding to a simulated dirty bomb attack. Other sessions throughout the week cover topics such as how Medicare and Medicaid reform are affecting insurance reimbursement of radiological procedures, medical errors, the impact of recent Nuclear Regulatory Commission training and experience regulations on the handlers of radioactive material in diagnosis and therapy, and reforms in the radiological health programs at the FDA.

HIGHLIGHTS OF THE SCIENTIFIC PROGRAM

The following is a sampling of some of the many noteworthy talks that medical physicists will present at the meeting.

I. PROMISING FIRST IMAGES FROM HUMAN CLINICAL TRIALS OF MAMMOGRAPHY ALTERNATIVE
II. LIGHTING UP RADIATION-RESISTANT TUMOR REGIONS
III. READING BETWEEN THE LINES OF MEDICAL-IMAGE INTERPRETATION
IV. TREATING LUNG CANCER WITH 4D PROTONS
V. HYBRID MACHINE PERFORMS MRI AND RADIATION THERAPY
VI. ELECTRON TECHNIQUE IMAGES CRUCIAL OXYGEN LEVELS

I. PROMISING FIRST IMAGES FROM HUMAN CLINICAL TRIALS OF MAMMOGRAPHY ALTERNATIVE

Researchers will present some of the first images from human clinical trials of breast CT imaging, a potential improvement over traditional mammography that aims to catch breast cancer earlier while eliminating patient discomfort. Traditional mammograms involve squeezing the breast between two plates and firing an x-ray that images the breast all at o
'"/>


28-Jun-2005


Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Antiprotons 4 times more effective than protons for cell irradiation
2. New proton therapy, breast CT clinical trials, radiation-resistant tumors
3. Study compares stomach acid control of three proton pump inhibitors in chronic NSAID users
4. RNAi shows promise in gene therapy, Stanford researcher says
5. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
6. Order of chemotherapy, radiation has no effect on breast cancer survival
7. Almost 1/3 of colon cancer patients stop chemotherapy, leading to double the death rate
8. No link between estrogen-only therapy, breast cancer in postmenopausal women
9. Talk therapy more effective long term treatment for SAD than light therapy, study finds
10. Star Trek-type scanning may reveal genetic activity of tumors, Stanford study shows
11. Blacks with bladder cancer have more aggressive tumors, worse survival, U-M study finds

Post Your Comments:
(Date:8/1/2014)... 2014 Parker Waichman LLP, a national ... injured by defective medical devices and drugs reports that ... Ethicon surgical power morcellator devices used for the removal ... the spread of cancer associated with power morcellators, according ... 2014. , Johnson & Johnson had previously ceased ...
(Date:8/1/2014)... Aug. 1, 2014 (HealthDay News) -- Almost 140 ... school transportation in the United States. But ... bus-related catastrophes, Dawne Gardner, injury prevention coordinator at ... Center, said in a medical center news release. ... returning to school, it,s important for parents and ...
(Date:8/1/2014)... The evolving healthcare landscape presents ... At ThoughtSpot 2014, AmerisourceBergen and Good Neighbor Pharmacy’s ... resources to enhance patient care and profitability. At ... issues to give independent pharmacists the tools they ... ThoughtSpot show attendance experienced a nearly 70% increase ...
(Date:8/1/2014)... DC (PRWEB) August 01, 2014 ... Thompson (D-CA), Gregg Harper (R-MS), and Peter Welch ... 5380, the Medicare Telehealth Parity Act of 2014, ... fully support this effort to improve healthcare access ... chief executive officer of ATA. "These cost-saving provisions ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 On Monday, ... California NextGen User Symposium in San Francisco, CA. Now ... at the JW Marriott Union Square hotel. , “We ... get up to speed with ACA compliance issues,” Quirk ... month. The symposium provides attendees guidance with NextGen implementation ...
Breaking Medicine News(10 mins):Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 3Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 4Health News:Expert Offers School Bus Safety Tips 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:ATA Applauds Bill on Medicare Telemedicine Improvements 2Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2
(Date:8/1/2014)... 1, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 3 study evaluating ISIS-SMN Rx in infants ... cause of infant mortality. Isis plans to dose the ... weeks, at which time Isis will earn an $18 ... The Phase 3 study, ENDEAR, is the first of ...
(Date:8/1/2014)... Pa. , Aug. 1, 2014 Inovio ... will host a conference call to report its second ... at 9:00 AM ET. CEO Dr. J. Joseph ... discuss second quarter earnings, provide a corporate update, and ... will include clinical development plans for VGX-3100, Inovio,s immune ...
(Date:8/1/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ... reported financial results for the second quarter ended ... continued to see encouraging advancements in the US ... in estimated total prescriptions and estimated total per ... Lief, Arena,s President and Chief Executive Officer. "Other ...
Breaking Medicine Technology:Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11
Cached News: